ArticleJournal of public health in Africa2022
Trend and enhanced surveillance of Monkeypox during COVID-19 pandemic in Nigeria.
Article in Journal of public health in Africa, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 4 syntheses or guidelines pooled it, 22 citations in OpenAlex.
- Pooled it
- Dynamics of Mpox infection in Nigeria: a systematic review and meta-analysis.Scientific reports · 2024Pooled it
- Global Epidemiological Features of Human Monkeypox Cases and Their Associations With Social-Economic Level and International Travel Arrivals: A Systematic Review and Ecological Study.International journal of public health · 2023Pooled it
- Clinical features, hospitalisation and deaths associated with monkeypox: a systematic review and meta-analysis.Annals of clinical microbiology and antimicrobials · 2022Pooled it
- Dynamics of Mpox epidemics by the interplay of COVID-19 pandemic in Africa.BMC medicine · 2026Article
- Monkeypox presenting as an isolated genital rash: a case report.Dermatology reports · 2025Article
- Review
- A cross-sectional survey of public knowledge of the monkeypox disease in Nigeria.BMC public health · 2023Article
- Mitigation Measures to Control the Expected Mpox Outbreak in a Developing Country-Pakistani Scenario.Vaccines · 2023Article
- The re-emergence and transmission of Monkeypox virus in Nigeria: the role of one health.Frontiers in public health · 2023Article
- National Monkeypox Surveillance, Central African Republic, 2001-2021.Emerging infectious diseases · 2022Article
- Monkeypox: Clinical Issues of Concern.Journal of translational internal medicine · 2022Article
- Epidemiological Situation of Monkeypox Transmission by Possible Sexual Contact: A Systematic Review.Tropical medicine and infectious disease · 2022Review
- Epidemiology of human Monkey-pox cases in Rivers State, Nigeria January 2017-June 2022.Frontiers in public health · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Monkeypox (MPX) is a viral zoonosis with lesions like smallpox. Though rare in Nigeria, sporadic outbreaks have been reported in 17 states since September 2017. Unfortunately, the COVID-19 pandemic has further reduced surveillance and reporting of MPX disease. This study seeks to assess the effect of an enhanced surveillance approach to detect MPX cases and measure the cumulative incidence of MPX in priority states in Nigeria. We identified three priority states (Rivers, Delta and Bayelsa) and their Local Government Areas (LGAs) based on previous disease incidence. We also identified, trained, and incentivized community volunteers to conduct active case searches over three months (January to March 2021). We supported case investigation of suspected cases and followed up on cases in addition to routine active surveillance for MPX in health facilities and communities. Weekly and monthly follow-up was carried out during the same period. Out of the three states, 30 hotspots LGAs out of the 56 LGAs (54%) were engaged for enhanced surveillance. We trained three state supervisors, 30 LGA surveillance facilitators and 600 Community informants across the three priority states. Overall, twenty-five (25) suspected cases of MPX were identified. Out of these, three (12%) were confirmed as positive. Enhanced surveillance improved reporting of MPX diseases in hotspots LGAs across the priority states. Extension of this surveillance approach alongside tailored technical support is critical intra and post-pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.